3086:HK:HK-BMO NASDAQ 100 HKD (HKD)

ETF | Others |

Last Closing

USD 40.48

Change

-0.06 (-0.15)%

Market Cap

N/A

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.48 (+2.25%)

USD 161.07B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+2.06 (+2.77%)

USD 20.18B
2801:HK iShares Core MSCI China ETF

+0.72 (+3.31%)

USD 17.71B
2823:HK iShares FTSE A50 China

+0.69 (+4.79%)

USD 14.19B
83188:HK ChinaAMC CSI 300 Index ETF

+2.10 (+5.28%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

+0.09 (+7.14%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.61 (+6.45%)

USD 9.22B
82822:HK CSOP FTSE China A50

+0.55 (+4.52%)

USD 7.65B
9010:HK iShares Core MSCI AC Asia ex J..

+0.05 (+0.59%)

USD 3.03B

ETFs Containing 3086:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.88% 71% C- 73% C
Dividend Return 0.12% 2% F N/A F
Total Return 18.00% 70% C- 71% C-
Trailing 12 Months  
Capital Gain 34.57% 85% B 84% B
Dividend Return 0.27% 3% F 1% F
Total Return 34.84% 84% B 83% B
Trailing 5 Years  
Capital Gain 159.82% 98% N/A 92% A
Dividend Return 1.35% 7% C- 5% F
Total Return 161.17% 98% N/A 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 25.78% N/A N/A 83% B
Dividend Return 25.97% N/A N/A 82% B
Total Return 0.18% N/A N/A 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 33.48% N/A N/A 45% F
Risk Adjusted Return 77.56% N/A N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike